Goldman Sachs Group Inc. Sells 176,258 Shares of Integer Holdings Co. (NYSE:ITGR)

Goldman Sachs Group Inc. cut its position in shares of Integer Holdings Co. (NYSE:ITGR) by 23.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 573,178 shares of the medical equipment provider’s stock after selling 176,258 shares during the period. Goldman Sachs Group Inc.’s holdings in Integer were worth $56,790,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of ITGR. Blue Trust Inc. raised its position in Integer by 483.3% in the fourth quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider’s stock worth $45,000 after purchasing an additional 377 shares in the last quarter. Principal Securities Inc. acquired a new position in shares of Integer in the 4th quarter worth approximately $67,000. Quadrant Capital Group LLC raised its holdings in shares of Integer by 10.2% in the 4th quarter. Quadrant Capital Group LLC now owns 1,427 shares of the medical equipment provider’s stock worth $141,000 after buying an additional 132 shares in the last quarter. Strs Ohio lifted its position in shares of Integer by 54.5% during the 4th quarter. Strs Ohio now owns 1,700 shares of the medical equipment provider’s stock worth $168,000 after buying an additional 600 shares during the period. Finally, Van ECK Associates Corp boosted its stake in Integer by 22.0% in the 3rd quarter. Van ECK Associates Corp now owns 1,733 shares of the medical equipment provider’s stock valued at $136,000 after buying an additional 313 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Trading Down 1.9 %

ITGR opened at $115.03 on Wednesday. Integer Holdings Co. has a 1-year low of $69.40 and a 1-year high of $123.99. The firm has a 50-day moving average price of $117.24 and a two-hundred day moving average price of $109.05. The stock has a market capitalization of $3.85 billion, a PE ratio of 39.80, a PEG ratio of 1.72 and a beta of 1.16. The company has a current ratio of 3.32, a quick ratio of 2.01 and a debt-to-equity ratio of 0.76.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share for the quarter, beating analysts’ consensus estimates of $1.12 by $0.02. Integer had a net margin of 6.01% and a return on equity of 11.25%. The business had revenue of $414.80 million during the quarter, compared to analyst estimates of $412.78 million. During the same quarter last year, the business posted $0.87 earnings per share. Integer’s revenue for the quarter was up 9.5% compared to the same quarter last year. As a group, equities analysts anticipate that Integer Holdings Co. will post 5.27 earnings per share for the current fiscal year.

Insider Activity

In other Integer news, VP Tommy P. Thomas sold 1,500 shares of the company’s stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of $114.00, for a total transaction of $171,000.00. Following the transaction, the vice president now directly owns 2,813 shares in the company, valued at approximately $320,682. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Integer news, VP Tommy P. Thomas sold 1,500 shares of Integer stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $114.00, for a total transaction of $171,000.00. Following the completion of the sale, the vice president now owns 2,813 shares of the company’s stock, valued at approximately $320,682. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Andrew Senn sold 5,000 shares of the stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $113.14, for a total value of $565,700.00. Following the completion of the transaction, the senior vice president now directly owns 4,658 shares in the company, valued at approximately $527,006.12. The disclosure for this sale can be found here. Insiders have sold 17,936 shares of company stock valued at $2,130,937 over the last 90 days. 2.00% of the stock is owned by company insiders.

Analyst Ratings Changes

Several research firms have issued reports on ITGR. Benchmark reiterated a “buy” rating and set a $130.00 price objective on shares of Integer in a research note on Friday, May 10th. CL King started coverage on shares of Integer in a report on Thursday, March 14th. They set a “buy” rating and a $137.00 price target for the company. Citigroup boosted their price target on shares of Integer from $118.00 to $124.00 and gave the company a “neutral” rating in a research report on Wednesday, May 22nd. Bank of America raised shares of Integer from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $105.00 to $135.00 in a report on Monday, April 15th. Finally, Truist Financial initiated coverage on Integer in a report on Wednesday, May 15th. They issued a “buy” rating and a $137.00 target price on the stock. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $128.00.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.